Categories: Prescription Medication
Description:
Hydralazine is a second-line antihypertensive used for acute management of severe hypertension in preeclampsia, especially when labetalol or nifedipine are not suitable or effective. It is administered intravenously and acts as a direct vasodilator, lowering blood pressure quickly. However, it can cause more maternal side effects like tachycardia and headaches compared to other agents, which limits its use as a first-line option.
Treatment For:
AI generated Summary: Based on the single review provided, Hydralazine appears to be an effective second-line treatment for managing severe hypertension in patients with preeclampsia. The review suggests that Hydralazine is used after other medications, such as labetalol or beta-blockers, to provide additional blood pressure control while minimizing the risk of reflex tachycardia.
Hydralazine is typically used after labetalol or other beta-blockers in preeclampsia to manage severe hypertension while minimizing the risk of reflex tachycardia. It serves as a second-line agent when additional blood pressure control is needed.
The information, including but not limited to, text, graphics, images and other material contained on this website/app are for informational purposes only. No material on this site/app is intended to be a substitute for professional medical advice, diagnosis or treatment. Always seek the advice of your physician or other qualified healthcare provider with any questions you may have regarding a medical condition or treatment and before undertaking a new health care regimen, and never disregard professional medical advice or delay in seeking it because of something you have read on this website/app.
Copyright © 2025,Curbside and related marks are registered trademarks of Curbside Tech Inc.
